https://www.selleckchem.com/pr....oducts/pilaralisib-x
To determine the serum hypoxia inducible factor-1, -2 and -3 (HIF-1, -2 and -3) levels in patients with laryngeal neoplasm, and to investigate their role in differential diagnosis, prediction of tumor characteristic and extension, and prognosis and survival. Prospective, cohort study at a tertiary referral center. The study was conducted in a tertiary medical centre. Patients with benign, premalignant and malignant laryngeal neoplasms were included. Sixty-four patients with a laryngeal neoplasm were enrolled. Serum HIF-1, -2,
Like
Comment
Share
